Funded Tech Companies
Precision BioSciences
Wondering who invested in Precision BioSciences? Amgen Ventures, Brace Pharma and DUMAC joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Precision BioSciences
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
302 East Pettigrew St. Dibrell Building A-100
Durham, NC 27701
USA
Durham, NC 27701
USA
Phone
Website
Email Address
Company Background Information
Overview
The Precision BioSciences (Nasdaq: DTIL) mission is to translate the world's most powerful genome editing technology into greatly needed products throughout the life sciences.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
3/27/2019
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Matthew Kane
Chief Scientific Officer
Derek Jantz
Vice President
Clayton Beard
VP - Bus. Development
Drew Applefield
VP - Bus. Development
Michael Dombeck
VP - Engineering
Victor Bartsevich
VP - Finance
Abid Ansari
VP - Marketing
Heather King
VP - Operations
Sinu Bhandaru
VP - Regulatory Affairs
Marcia Gaido
Company Investors
- Amgen Ventures
- Brace Pharma
- DUMAC
- Alexandria Venture Investments
- Adage Capital Management
- Vivo Capital
- Cowen Capital Partners
- venBio (Robert Adelman)
- Agent Capital
- Osage Partners
- F-Prime Capital
- OCV Partners
- RA Capital
- Gilead Sciences
- Longevity Fund
- Pontifax AgTech
- Ridgeback Capital
- Cormorant Asset Management
- ArrowMark Partners
- Franklin Templeton
Browse more funded tech companies:
Precision Biopsy | Precision Compounding Pharmacy
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs